LG
Ligand Pharmaceuticals, Inc.
LGNXZ · OTC
$0.00 +22.28% (+$0.00)
1M +22.28%
Market Cap $90.2K
P/E Ratio 0.00x
Div. Yield -
ROE 20.06%
Piotroski F-Score Moderate
5/9Valuation
100 /100
Cheap EV/EBITDA 0.72x
P/S 0.00x
P/B 0.00x
Growth
77 /100
Growing Book val. growth 8.00%
Rev. growth 17.72%
FCF growth N/A
Profitability
100 /100
Strong Net margin 67.88%
Op. margin 34.45%
FCF margin 45.24%
Quality
49 /100
Average ROE 20.06%
ROA 9.02%
Asset turnover 0.13x
Debt
82 /100
Low Current ratio 30.49x
Int. coverage 22.22x
Net debt/EBITDA 0.72x
Stability
31 /100
Unstable Rev. volatility 37.46%
EPS volatility 1,194.95%
Profitable years 2
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LGNXZ
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Todd C. Davis
Employees
47
Headquarters
Jupiter
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report